KCT0006049进行中(未招募)未知
A comparison of the analgesic efficacy of pericapsular nerve group blocking vs periarticular injection after total hip arthroplaslty - Prospective study
试验速览
- 阶段
- 未知
- 状态
- 进行中(未招募)
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 0No Limit(—)
- 性别
- All
入选标准
- •1) Men and women over 18 years of age
- •2) Patients who underwent total hip arthroplasty under the diagnosis of arthritis after the IRB approval date
- •3) Patients who have completed the survey among patients admitted to the hospital for more than 48 hours after surgery
排除标准
- •1) Patients who were hospitalized for more than 48 hours after surgery and did not faithfully participate in the survey, or were discharged within 48 hours unplanned and failed to complete the survey
- •2) Patients who have undergone total hip arthroplasty due to reoperation, infectious disease, or fracture rather than simple total hip arthroplasty.
- •3) Patients with side effects related to nerve group blockage before surgery or periarticular capsule injection during surgery
- •4) Patients with diseases such as delirium/dementia are excluded
- •5) If the patient does not agree to participate in the test
研究者
相似试验
进行中(未招募)
Unknown
COMPARISON BETWEEN PERICAPSULAR NERVE GROUP BLOCK AND FASCIA ILIACA COMPARTMENT BLOCK IN FEMUR FRACTURESCTRI/2023/09/057737AMITA MALLANNA HIPPARAGI
招募中
3 期
Analgesic effect of pericapsular nerve and fascia iliaca block in hip fractureIRCT20170516033992N8Oroumia University of Medical Sciences40
尚未招募
4 期
A comparative study of Dexamethasone by two different routes as an adjuvant to Ropivacaine in USG guided supraclavicular block for upper limb surgeriesCTRI/2023/06/054070DR RAJENDRA PRASAD GOVERNMENT MEDICAL COLLEGE TANDA
进行中(未招募)
1 期
Evaluation of the efficacy of a new paracetamol formulation for buccal use after a single dose in patients with a moderate pain after a wisdom tooth extraction.EUCTR2020-002220-37-ITITHER PHARMACEUTICALS404
进行中(未招募)
1 期
Evaluation of the efficacy of a new paracetamol formulation for buccal use after a single dose in patients with a moderate pain after a wisdom tooth extraction.Symptomatic short-term treatment of moderate painEUCTR2020-002220-37-FRITHER Pharmaceuticals404
